Icon times
Yatharth Hospital & Trauma Care Services

Yatharth Hospital & Trauma Care Services

CompanyOver

 / 
 
 

About

Highlights

Performing rate for the company

Track the companies of Group.

Relaince Group

Sector: Refineries

Market Price

2,529.50

Market Cap(₹Cr.)

2,529.50

-90.00

Quarterly Results ( Figures in Rs. Crores.)

No Data is available.

Profit & Loss ( Figures in Rs. Crores.)

No Data is available.

Balance Sheet ( Figures in Rs. Crores.)

No Data is available.

Cash Flows ( Figures in Rs. Crores.)

No Data is available.

Historical Growths

Compounded Sales Growth
Compounded Profit Growth
Compounded Expense Growth
Stock Price CAGR
No data is available
Sales Growth Profit Growth Expense Growth Stock Price CAGR

Ratios ()

No Data is available.

Major Shareholders

No Data is available.

Shareholders more than 1%

No Data is available.

Fund houses invested in the stock (Figures in % Equity Capital )

No Data is available.

Corporate Action

No Data is available.
No Data is available.
No Data is available.
No Data is available.

Documents

Presentation & Earning Calls

Annual Reports

Credit Rating

No document is available
No document is available
No document is available
No document is available.

Overview

Yatharth Hospital & Trauma Care Services is a network of super speciality hospitals across Delhi National Capital Region (NCR) and Madhya Pradesh, capitalising on the robust healthcare infrastructure in these regions to serve a wide patient base in need of tertiary care. The company’s hospitals have been designed to comply with international quality standards with its Noida Extension Hospital accredited by Joint Commission International (JCI), USA and all its hospitals accredited by the National Accreditation Board for Hospitals (NABH). The company’s hospitals have been built on a foundation of talent, trust, technology, service and infrastructure. 

All of its hospitals offer spacious suites along with modern deluxe and super deluxe rooms, and comfortable patient waiting areas. The company’s diagnostic areas are designed with the goals of providing patient-friendly, spacious and relaxing environments. The company has advanced medical equipment such as Azurion catheterization laboratory and are equipped with the latest robotics surgical equipments like the DaVinci, Mako and Cuvis, 1.5 Tesla whole-body MRI with optical digital broadband and embedded express coil technology for minimal patient repositioning and advanced non-contrast MR Angiography, 128 slice CT scan, endo bronchial ultrasound, nerve conduction velocity (NCV), advanced surgical equipment including Thulium Uro laser, flexible scope, advance laparoscope, advance microscopes, Cusa set. These advanced equipments provide for a better and more accurate diagnosis, as well as insight into the surgical procedure, which increases the surgical success rate.

Some of its modular operation theatres are equipped with high efficiency particulate air (HEPA) filters and laminar flow, operating microscopes with image intensifiers. The company’s in-house diagnostic radiology setup and diagnostic labs are well-equipped centres with comprehensive diagnostic capabilities including, haematology, biochemistry, microbiology, molecular biology and histopathology along with 24x7 in-house pharmacy shops.

Business area of the company 

The company is engaged in the business of providing healthcare services, operating hospitals and other allied services, as may be required for the provision of healthcare services. The company has one hospital each in Noida and Greater Noida.

Awards and Accreditations

  • 2020: Recognized as Emerging Hospital Chain in Delhi NCR by Medico Trip India.
  • 2020: Awarded 1stPrize in Swachhta Ranking Competition in the category of Swachh Hospital (for the quarter ended June 2019) in compliance with Swachh Survekshan League 2020 by Noida Authority.
  • 2020: Awarded 1st Rank in Swachhta Ranking Competition in the category of Swachh Hospital (for the quarter ended September 2019) in compliance with Swachh Survekshan League 2020 by Noida Authority.
  • 2021: Certificate of appreciation as ‘Heroes’-Beyond the Call of Duty from Tata Consultancy Services.
  • 2021: Covid Thank You Award by Niva Bupa.
  • 2021: 5 star grading by Infomerics Analysts & Research Private Limited for its hospitals located at Noida, Noida Extension and Greater Noida.
  • 2023: Awarded UP Ratan Samman by Dainik Jagran Inext.
  • 2024-25: Awarded the Best Brand for Excellence in Healthcare at the Economic Times (ET) Edge Best Brands Conclave, in recognition to its consistent innovation and customer-centric approach
  • 2024-25: Noida Extension Hospital accredited by Joint Commission International (JCI) – the first hospital in Uttar Pradesh and seventh in North India to receive this prestigious global accreditation

Milestones

  • 2008: Incorporated the Company and commenced operations
  • 2010: Established first hospital in Greater Noida
  • 2013: Established its second hospital, a 250-bed hospital facility in Noida
  • 2018: Expanded its first hospital, Greater Noida hospital to 400 beds
  • 2019: Commenced operations of its third hospital in, Noida Extension, in May 2019, following the acquisition of its subsidiary AKS in 2016
  • 2022: Acquired its fourth hospital, the Jhansi Orchha hospital, adding 305 beds, through the acquisition of Ramraja Multispeciality Hospital
  • 2023: Listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE)
  • 2024: Acquired its fifth hospital, in Faridabad, Delhi NCR, adding 200 beds
  • 2025: Successfully acquired two hospital, first in Model Town , Delhi and second in Sector 20, Faridabad, Haryana

Brands Of Yatharth Hospital & Trauma Care Services

Brands Of Yatharth Hospital & Trauma Care Services

undefined

Comment

Chat on WhatsApp
Caret UP Arrow
InvestYadnya Support
Typically replies in minutes
InvestYadnya Support
Hi there
Welcome to InvestYadnya.
We are available to assist you on WhatsApp.
Please click on the button below to chat with us.
(10 AM to 7 PM IST)
16:10
Chat with InvestYadnya